Annual Total Liabilities
$26.34 M
+$1.16 M+4.60%
December 31, 2023
Summary
- As of February 8, 2025, EFTR annual total liabilities is $26.34 million, with the most recent change of +$1.16 million (+4.60%) on December 31, 2023.
- During the last 3 years, EFTR annual total liabilities has fallen by -$122.61 million (-82.32%).
- EFTR annual total liabilities is now -82.32% below its all-time high of $148.95 million, reached on December 31, 2020.
Performance
EFTR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$26.30 M
-$35.00 K-0.13%
March 31, 2024
Summary
- As of February 8, 2025, EFTR quarterly total liabilities is $26.30 million, with the most recent change of -$35.00 thousand (-0.13%) on March 31, 2024.
- Over the past year, EFTR quarterly total liabilities has dropped by -$437.00 thousand (-1.63%).
- EFTR quarterly total liabilities is now -82.34% below its all-time high of $148.95 million, reached on December 31, 2020.
Performance
EFTR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
EFTR Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.6% | -1.6% |
| 3 y3 years | -82.3% | -1.6% |
| 5 y5 years | -82.3% | -1.6% |
EFTR Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -28.4% | +4.6% | -28.5% | +10.3% |
| 5 y | 5-year | -82.3% | +4.6% | -82.3% | +10.3% |
| alltime | all time | -82.3% | +4.6% | -82.3% | +10.3% |
EFFECTOR Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $26.30 M(-0.1%) |
| Dec 2023 | $26.34 M(+4.6%) | $26.34 M(+9.2%) |
| Sep 2023 | - | $24.13 M(-0.8%) |
| Jun 2023 | - | $24.31 M(-9.1%) |
| Mar 2023 | - | $26.74 M(+6.2%) |
| Dec 2022 | $25.18 M | $25.18 M(+0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $25.09 M(+5.2%) |
| Jun 2022 | - | $23.85 M(-1.7%) |
| Mar 2022 | - | $24.26 M(-34.0%) |
| Dec 2021 | $36.77 M(-75.3%) | $36.77 M(-45.6%) |
| Sep 2021 | - | $67.61 M(-54.6%) |
| Dec 2020 | $148.95 M | $148.95 M |
FAQ
- What is eFFECTOR Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics annual total liabilities year-on-year change?
- What is eFFECTOR Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics quarterly total liabilities year-on-year change?
What is eFFECTOR Therapeutics annual total liabilities?
The current annual total liabilities of EFTR is $26.34 M
What is the all time high annual total liabilities for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high annual total liabilities is $148.95 M
What is eFFECTOR Therapeutics annual total liabilities year-on-year change?
Over the past year, EFTR annual total liabilities has changed by +$1.16 M (+4.60%)
What is eFFECTOR Therapeutics quarterly total liabilities?
The current quarterly total liabilities of EFTR is $26.30 M
What is the all time high quarterly total liabilities for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high quarterly total liabilities is $148.95 M
What is eFFECTOR Therapeutics quarterly total liabilities year-on-year change?
Over the past year, EFTR quarterly total liabilities has changed by -$437.00 K (-1.63%)